Skip to Content
Merck

199257

L-(+)-Lactic acid solution

in H2O, ≥85%

Synonym(s):

(S)-(+)-Lactic acid, (S)-2-Hydroxypropionic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
CH3CH(OH)CO2H
CAS Number:
Molecular Weight:
90.08
UNSPSC Code:
12161700
NACRES:
NA.25
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1720251
Assay:
≥85%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥85%

optical activity

[α]20/D −13.5°, c = 2.5 in 1.5 M NaOH

concentration

in H2O

refractive index

n20/D 1.427

density

1.206 g/mL at 25 °C

SMILES string

C[C@H](O)C(O)=O

InChI

1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1

InChI key

JVTAAEKCZFNVCJ-REOHCLBHSA-N

Other Notes

Contains varying amounts of intermolecular esterification products
Most salts of L-(+)-lactic acid are levorotatory, hence the negative rotation in NaOH solution.


Still not finding the right product?

Explore all of our products under L-(+)-Lactic acid solution


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1C

supp_hazards

Storage Class

8A - Combustible corrosive hazardous materials

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



T Isotalo et al.
BJU international, 88(1), 30-34 (2001-07-12)
To assess whether patients in acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising finasteride and a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent. Fifty-five patients in acute urinary retention were treated as
Ariadna Montero-Blay et al.
Cell reports, 31(9), 107722-107722 (2020-06-04)
Here, we propose an approach to identify active metabolic pathways by integrating gene essentiality analysis and protein abundance. We use two bacterial species (Mycoplasma pneumoniae and Mycoplasma agalactiae) that share a high gene content similarity yet show significant metabolic differences.
Franco Valenza et al.
Critical care (London, England), 9(6), 588-593 (2005-12-17)
Lactate measurement in the critically ill has been traditionally used to stratify patients with poor outcome. However, plasma lactate levels are the result of a finely tuned interplay of factors that affect the balance between its production and its clearance.